drugset / Trial / NCT00771160

MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)

NCT00771160

Phase 3 Completed 120 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

A clinical study evaluates the efficacy and safety of MK0476 in adult patients with Perennial Allergic rhinitis.

Timeline

Start
2004-09
Primary completion
2005-02
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 5 mg
Subject Montelukast Other / unclassified 10 mg

Indications